Table 1.

Patients Coinfected With COVID-19 and CCHF Reported From Turkey

Author	Age, y	Sex	Signs & Symptoms	Examination	Abnormal Laboratory Findings	Tick Exposure	COVID-PCR	CCHF-PCR	Thorax CT	Treatment	Outcome
Buyuktuna SA, et al⁴	35	Female	Fever, body pain	Body temperature 38 °C, respiratory rate 22, other examination is normal	Leukopenia, thrombocytopenia, increased levels of ALT, AST, D-dimer, CRP, prolonged INR	Yes	+	+	Cystic bronchiectasic changes in apical, posterior, and anterior segments of upper lobe of the right lung and superior and posterior segments of lower lobe of the left lung	Favipiravir	Survived
Dulger AC, et al⁵	65	Male	Dry cough, myalgia and fever	Oxygen saturation 95% on ambient air, other examination is normal	Pancytopenia, increased levels of ALT, AST, D-dimer	Not described	+	+	Multiple bilateral peripheral ground-glass opacities	Favipiravir	Survived

Note. PCR, polymerase chain reaction; CCHF, Crimean–Congo hemorrhagic fever; CT, computed tomogram; ALT, alanine transaminase; AST, aspartate transaminase; CRP, C-reactive protein; INR, international normalization ratio.